Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:BABY

Natus Medical (BABY) Stock Price, News & Analysis

Natus Medical logo

About Natus Medical Stock (NASDAQ:BABY)

Key Stats

Today's Range
N/A
50-Day Range
$26.75
$31.92
52-Week Range
N/A
Volume
22 shs
Average Volume
165,325 shs
Market Capitalization
$1.12 billion
P/E Ratio
23.21
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Natus Medical Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
43rd Percentile Overall Score

BABY MarketRank™: 

Natus Medical scored higher than 43% of companies evaluated by MarketBeat, and ranked 723rd out of 958 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Natus Medical.

  • Earnings Growth

    Earnings for Natus Medical are expected to grow by 24.41% in the coming year, from $1.27 to $1.58 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Natus Medical is 23.21, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 280.66.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Natus Medical is 23.21, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 76.39.

  • Short Interest

    There is no current short interest data available for BABY.
  • Dividend Yield

    Natus Medical does not currently pay a dividend.

  • Dividend Growth

    Natus Medical does not have a long track record of dividend growth.

  • Short Interest

    There is no current short interest data available for BABY.
  • Search Interest

    3 people have searched for BABY on MarketBeat in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Natus Medical insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 1.65% of the stock of Natus Medical is held by insiders.

  • Percentage Held by Institutions

    91.56% of the stock of Natus Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Natus Medical's insider trading history.
Receive BABY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Natus Medical and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

BABY Stock News Headlines

$100 Trillion “AI Metal” Found in American Ghost Town
Jeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could be the biggest technology story of this decade. In short, he believes what he's holding in his hand is the key to the $100 trillion AI boom… And only one company here in the U.S. can mine this obscure metal.tc pixel
See More Headlines

BABY Stock Analysis - Frequently Asked Questions

Natus Medical Inc (NASDAQ:BABY) announced its earnings results on Wednesday, October, 24th. The medical equipment provider reported $0.40 earnings per share for the quarter, missing analysts' consensus estimates of $0.42 by $0.02. The company's revenue was up 6.5% on a year-over-year basis.

Natus Medical (BABY) raised $9 million in an initial public offering on Wednesday, March 8th 2023. The company issued 1,766,618 shares at a price of $5.00 per share.

Based on aggregate information from My MarketBeat watchlists, some other companies that Natus Medical investors own include Bristol Myers Squibb (BMY), Meta Platforms (META), Starbucks (SBUX), Intel (INTC), Walt Disney (DIS), Gilead Sciences (GILD) and Activision Blizzard (ATVI).

Company Calendar

Last Earnings
10/24/2018
Today
9/17/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Electromedical Equipment
Sub-Industry
Health Care Equipment
Current Symbol
NASDAQ:BABY
CIK
878526
Fax
N/A
Employees
1,729
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
$1.42
Trailing P/E Ratio
23.21
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$22.93 million
Net Margins
-7.38%
Pretax Margin
N/A
Return on Equity
10.79%
Return on Assets
6.57%

Debt

Debt-to-Equity Ratio
0.18
Current Ratio
1.70
Quick Ratio
1.18

Sales & Book Value

Annual Sales
$530.89 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
9.39
Book Value
$11.80 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
34,010,000
Free Float
N/A
Market Cap
$1.12 billion
Optionable
Optionable
Beta
0.57
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (NASDAQ:BABY) was last updated on 9/17/2025 by MarketBeat.com Staff
From Our Partners